Peptide therapy has moved from niche biohacking circles into mainstream medicine, and the regulatory landscape around it is actively evolving. In this panel discussion, Shaun Noorian (Founder & CEO, Empower Pharmacy), Dr. Rekha Kumar (Senior Medical Advisor, Found), and Dr. Alex Tatem (Corporate Director of Men's Health, U.S. Urology) join moderator Christina Farr (CEO, Second Opinion; GP, Scrub Capital) to unpack what responsible, evidence-based peptide therapy looks like today. Watch the full conversation below.

_{Like all compounded drug products, compounded peptides dispensed from a 503A facility are available only pursuant to a valid prescription from a licensed healthcare provider for a specific patient. No compounded products are FDA-approved or evaluated by the FDA for safety or efficacy. The information presented in this webinar reflects the opinions of the individual participants and is not intended to constitute medical advice, representations, or claims of any peptide's fitness to treat a specific condition or disease.}